PACTR201710002685398Other未知
Dobutamine and Nitroglycerine versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery
menoufiya faculty of medicine0 个研究点目标入组 40 人开始时间: 2017年10月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- Other
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 22 Year(s) 至 45 Year(s)（—）
- 性别
- All
入选标准
- •The inclusion criteria were patients with mitral valve disease aged between 22 to 45 years old of both sexes having PAP ranged from 65 to 110 mmHg and scheduled for elective mitral valve replacement.
排除标准
- •The Exclusion criteria were patients with Severely reduced myocardial function i.e. left ventricular ejection fraction <45%, Severe liver insufficiency, Renal insufficiency (serum creatinine >2.0 mmol/L), Severe chest disease or COPD patients, Pulmonary valve disease or replacement, Recent pacemaker insertion, left bundle branch block, Wolf Parkinson-White Syndrome or Ebstein¿s anomaly and Recent stroke.
研究者
相似试验
尚未招募
Unknown
Milrinone versus dobutamine as supportive agent for right ventricular dysfunction after cardiopulmonary bypass: a prospective randomized comparative studyJPRN-UMIN000054149Mansoura university hospitals54
已完成
3 期
Comparison of the effect of milrinone and dobutamine on pulmonary hypertensioPulmonary hypertension.Other secondary pulmonary hypertensionI27.2IRCT20211102052941N1Esfahan University of Medical Sciences38
招募中
不适用
effect of nebulized milrinone and intravenous milrinone in patients with pulmonary hypertentioI27.2Pulmonary HTN.Other secondary pulmonary hypertensionIRCT20201104049266N1Ahvaz University of Medical Sciences16
已完成
不适用
Milrinone in status asthmaticusRespiratorybronchial asthmaPACTR201802002998973dramrsobhy50
招募中
不适用
Comparative study of efficacy of minodronate, alendronate and risedronate in patients with osteoporosisOsteoporosisJPRN-UMIN000011407Kushiro-sanjikai Hospital150